H.R. 4121

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

Sponsor: Andy Harris · 0 cosponsors

Follow this bill

Official summary

Written by the Congressional Research Service.

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

This bill provides FY2026 appropriations for the Department of Agriculture (USDA), the Food and Drug Administration, and related agencies.

The bill provides appropriations to USDA for agricultural programs, including

  • the Office of the Secretary,
  • Executive Operations,
  • the Economic Research Service,
  • the National Agricultural Statistics Service,
  • the Agricultural Research Service,
  • the National Institute of Food and Agriculture,
  • the Animal and Plant Health Inspection Service,
  • the Agricultural Marketing Service, and
  • the Food Safety and Inspection Service.

The bill also provides appropriations to USDA for farm production and conservation programs, including

  • the Farm Production and Conservation Business Center,
  • the Farm Service Agency,
  • the Risk Management Agency, and
  • the Natural Resources Conservation Service.

The bill provides appropriations to the Federal Crop Insurance Corporation Fund and the Commodity Credit Corporation Fund.

For USDA rural development programs, the bill includes appropriations for

  • Salaries and Expenses,
  • the Rural Housing Service,
  • the Rural Business-Cooperative Service, and
  • the Rural Utilities Service.

The bill provides appropriations to the Food and Nutrition Service for

  • Child Nutrition Programs;
  • the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC);
  • the Supplemental Nutrition Assistance Program (SNAP);
  • the Commodity Assistance Program; and
  • Nutrition Programs Administration.

The bill provides appropriations to the Foreign Agricultural Service for (1) Food for Peace Title II Grants, and (2) McGovern-Dole International Food for Education and Child Nutrition Program Grants.

The bill also provides appropriations for

  • the Food and Drug Administration,
  • the Commodity Futures Trading Commission, and
  • the Farm Credit Administration.

Additionally, the bill sets forth requirements and restrictions for using funds provided by this and other appropriations acts.

Text of the bill

Expand all

I AGRICULTURAL PROGRAMS

II

III RURAL DEVELOPMENT PROGRAMS

IV

V FOREIGN ASSISTANCE AND RELATED PROGRAMS

VI

VII GENERAL PROVISIONS

Sec. 759.

Section 297A of the Agricultural Marketing Act of 1946 (7 U.S.C. 1639o) is amended—

(1) by redesignating paragraphs (2) through (6) as paragraphs (4) through (8), respectively; and

(2) by striking paragraph (1) and inserting the following:

Text this section adds to the law

(1) Hemp

(A) In General. The term ‘hemp’ means the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a total tetrahydrocannabinol concentration (including tetrahydrocannabinolic acid) of not more than 0.3 percent in the plant on a dry weight basis.

(B) Inclusion. Such term includes industrial hemp.

(C) Exclusions. Such term does not include—

(i) any viable seeds from a Cannabis sativa L. plant that exceeds a total tetrahydrocannabinol concentration (including tetrahydrocannabinolic acid) of 0.3 percent in the plant on a dry weight basis; or

(ii) any hemp-derived cannabinoid products containing—

(I) cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant;

(II) cannabinoids that—

(aa) are capable of being naturally produced by a Cannabis sativa L. plant; and

(bb) were synthesized or manufactured outside the plant; or

(III) quantifiable amounts based on substance, form, manufacture, or article (as determined by the Secretary of Health and Human Services in consultation with the Secretary of Agriculture) of—

(aa) tetrahydrocannabinol (including tetrahydrocannabinolic acid); or

(bb) any other cannabinoids that have similar effects (or are marketed to have similar effects) on humans or animals as tetrahydrocannabinol (as determined by the Secretary of Health and Human Services in consultation with the Secretary Agriculture).

(2) Industrial Hemp. The term industrial hemp means hemp—

(A) grown for the use of the stalk of the plant, fiber produced from such a stalk, or any other non-cannabinoid derivative, mixture, prep-aration, or manufacture of such a stalk;

(B) grown for the use of the whole grain, oil, cake, nut, hull, or any other non-cannabinoid compound, derivative, mixture, preparation, or manufacture of the seeds of such plant;

(C) grown for purposes of producing microgreens or other edible hemp leaf products intended for human consumption that are derived from an immature hemp plant that is grown from seeds that do not exceed the threshold for total tetrahydrocannabinol con-centration specified in paragraph (1)(C)(i);

(D) that is a plant that does not enter the stream of commerce and is intended to support hemp research at an institution of higher education (as defined in section 101 of the Higher Education Act of 1965 (20 U.S.C. 1001)) or an independent research institute; or

(E) grown for the use of a viable seed of the plant produced solely for the production or manufacture of any material described in subparagraphs (A) through (D).

(3) Hemp-Derived Cannabinoid Product

(A) In General. The term ‘hemp-derived cannabinoid product’ means any intermediate or final product derived from hemp (other than industrial hemp), that—

(i) contains cannabinoids in any form; and

(ii) is intended for human or animal use through any means of application or administration, such as inhalation, ingestion, or topical application.

(B) Exclusion. Such term does not include a drug that is the subject of an application approved under subsection (c) or (j) of section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355).